Investigational therapeutic shows promise in preclinical pancreatic cancer model retrieved 8 April 2024 from https://medicalxpress.com/news/2024-04-therapeutic-preclinical-pancreatic-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.1 hour agoUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Investigational gene therapy shows promise for rare childhood neurodegenerative diseaseAn investigational gene therapy for a rare neurodegenerative disease that begins in early childhood, known as giant axonal neuropathy (GAN), was well tolerated and showed signs of therapeutic benefit in a clinical trial led by the National Institutes of Health.
Source: NewsMedical - 🏆 19. / 71 Read more »
Clinical trial data show investigational cancer vaccine may elicit lasting immune response in pancreatic cancerNew data presented by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate, autogene cevumeran, continues to show potential to stimulate an immune response that may reduce the risk of the disease returning after...
Source: medical_xpress - 🏆 101. / 51 Read more »
Experimental gene therapy for giant axonal neuropathy shows promise in clinical trialAn investigational gene therapy for a rare neurodegenerative disease that begins in early childhood, known as giant axonal neuropathy (GAN), was well tolerated and showed signs of therapeutic benefit in a clinical trial led by the National Institutes of Health (NIH).
Source: medical_xpress - 🏆 101. / 51 Read more »
Clinical trial data show investigational cancer vaccine may elicit lasting immune response in pancreatic cancerNew data presented by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate, autogene cevumeran, continues to show potential to stimulate an immune response that may reduce the risk of the disease returning after...
Source: medical_xpress - 🏆 101. / 51 Read more »